Portfolio
We are developing the first oral FcRn inhibitors and best-in-class long-acting injectable FcRn inhibitors.
Monthly Peptide
FcRn
Orthosteric Modulator
Enablement
Hit Finding
Hit-to-Lead
Lead Optimization
IND Enabling
IND Enabling
Oral Peptide
FcRn
Orthosteric Modulator
Enablement
Hit Finding
Hit-to-Lead
Lead Optimization
IND Enabling
Lead Optimization
Oral Small Molecule
FcRn
Allosteric Modulator
Enablement
Hit Finding
Hit-to-Lead
Lead Optimization
IND Enabling
Hit-to-Lead